MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Impulse control and pain : a link in Parkinson’s disease.

    G. Albani, L. Pradotto, G. Veneziano, P. Cipresso, E. Pedroli, F. Scarpina, A. Mauro, M. Semonella, A. Cistaro (Piancavallo-Verbania, Italy)

    Objective: To find a correlation between  off-related pain, and dopaminergic dysregulation syndrome (DDS );  to investigate in a subgroup of patients the neural underpinnings of…
  • 2019 International Congress

    Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease

    X. Chai, S. Diwakarla, R. Pustovit, R. Mcquade, M. Di Natale, C. Ermine, C. Parish, D. Finkelstein, J. Furness (Melbourne, Australia)

    Objective: To characterize the gastrointestinal (GI) phenotype in the 6-hydroxydopamine (6OHDA) rat model of Parkinson’s disease (PD). Background: GI dysfunction, such as prolonged GI transit…
  • 2019 International Congress

    Transient orthostatic blood pressure changes in Parkinson’s Disease: impact on falls, syncope and orthostatic intolerance

    A. Fanciulli, N. Campese, G. Goebel, J. Ndayisaba, S. Eschlboeck, C. Kaindlstorfer, C. Raccagni, R. Granata, U. Bonuccelli, R. Ceravolo, W. Poewe, G. Wenning (Innsbruck, Austria)

    Objective: To assess the prevalence of transient orthostatic blood pressure (BP) changes and their influence on falls, syncope and orthostatic symptoms in Parkinson's disease (PD).…
  • 2019 International Congress

    Olfactory dysfunction in Parkinson’s disease

    N. Jalami, H. Bentahar, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: It is to propose a psychophysical test of the olfactory function. Its originality is to use Moroccan odorous products belonging to our culture to…
  • 2019 International Congress

    Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study

    J. Marín-Lahoz, F. Sampedro, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To longitudinally evaluate the role of depression in the development of impulse control disorders (ICD) in Parkinson's disease (PD) patients. Background: Depression has been…
  • 2019 International Congress

    Integrity of Mirror Neuron System in cervical dystonia: an fMRI study

    A. Castagna, S. Di Tella, V. Blasi, M. Cabinio, F. Baglio (Milano, Italy)

    Objective: To exploit the motor resonance mechanism of the mirror neuron system (MR-MNS) [1] in the rehabilitation of Cervical Dystonia (CD), we investigated its functional…
  • 2019 International Congress

    Grey matter atrophy in Parkinson’s disease with long-duration response

    G. Donzuso, G. Sciacca, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: Aim of the study is to investigate neuroanatomical correlates of Long-Duration Response using structural magnetic resonance imaging (MRI) and voxel-based morphometry analysis. Background: Parkinson…
  • 2019 International Congress

    Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study

    N. Holland, S. Jones, J. Woodside, E. Jabbari, V. Chelban, A. Costantini, PN. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, H. Morris, J. Rowe (Cambridge, United Kingdom)

    Objective: To investigate grey matter volume in typical and variant Parkinson-plus syndromes, to correlate these with disease severity, and to assess regional atrophy within disease…
  • 2019 International Congress

    18F-DPA714 PET reveals neuroinflammatory activity in the Substantia nigra of patients with Parkinson disease

    S. Lavisse, C. Wimberley, S. Goutal, M. Bottlaender, B. Kuhnast, MA. Peyronneau, M. Sarazin, P. Hantraye, C. Thiriez, P. Remy (Fontenay Aux Roses, France)

    Objective: We investigated whether 18F-DPA714 imaging could be a sensitive marker of neuroinflammation in Parkinson disease (PD). We took into account the polymorphism of TSPO…
  • 2019 International Congress

    Is 18F-FDG-PET/CT a helpful tool to diagnose PSP clinical variants?

    G. Marti-Andres, M. Riverol-Fernandez, R. Valentí-Azcárate, M. Fernández-Matarrubia, E. Prieto-Azcárate, J. Arbizu-Azcarate, MR. Luquin-Piudo (Pamplona, Spain)

    Objective: To assess if there are differential metabolic brain patterns among Progressive Supranuclear Palsy(PSP) clinical variants and between them and Parkinson’s disease patients (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 86
  • 87
  • 88
  • 89
  • 90
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley